Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 577 to 582 of 582 entries
Sorted by: Best Match Show Resources per page
Dietary organic selenium improves growth, serum biochemical indices, immune responses, antioxidative capacity, and modulates transcription of stress-related genes in Nile tilapia reared under sub-optimal temperature.

Journal of thermal biology

Naiel MAE, Negm SS, Abd El-Hameed SAA, Abdel-Latif HMR.
PMID: 34420631
J Therm Biol. 2021 Jul;99:102999. doi: 10.1016/j.jtherbio.2021.102999. Epub 2021 May 21.

A 56-day feeding experiment was carried out to investigate the influences of dietary organic selenium (OS) on the growth, body composition, serum biochemistry, stress responses, and immune indices of Nile tilapia reared under sub-optimal temperature. Fish (5.61 ± 0.5...

Cite
Naiel MAE, Negm SS, Abd El-Hameed SAA, et al. Dietary organic selenium improves growth, serum biochemical indices, immune responses, antioxidative capacity, and modulates transcription of stress-related genes in Nile tilapia reared under sub-optimal temperature. J Therm Biol. 2021;99:102999doi: 10.1016/j.jtherbio.2021.102999.
Naiel, M. A. E., Negm, S. S., Abd El-Hameed, S. A. A., & Abdel-Latif, H. M. R. (2021). Dietary organic selenium improves growth, serum biochemical indices, immune responses, antioxidative capacity, and modulates transcription of stress-related genes in Nile tilapia reared under sub-optimal temperature. Journal of thermal biology, 99102999. https://doi.org/10.1016/j.jtherbio.2021.102999
Naiel, Mohammed A E, et al. "Dietary organic selenium improves growth, serum biochemical indices, immune responses, antioxidative capacity, and modulates transcription of stress-related genes in Nile tilapia reared under sub-optimal temperature." Journal of thermal biology vol. 99 (2021): 102999. doi: https://doi.org/10.1016/j.jtherbio.2021.102999
Naiel MAE, Negm SS, Abd El-Hameed SAA, Abdel-Latif HMR. Dietary organic selenium improves growth, serum biochemical indices, immune responses, antioxidative capacity, and modulates transcription of stress-related genes in Nile tilapia reared under sub-optimal temperature. J Therm Biol. 2021 Jul;99:102999. doi: 10.1016/j.jtherbio.2021.102999. Epub 2021 May 21. PMID: 34420631.
Copy Download .nbib Format: NLM
Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?.

Cureus

Noor M, Haq M, Ul Haq N, Amin S, Rahim F, Bahadur S, Ullah R, Khan MA, Mahmood A, Gul H.
PMID: 33194502
Cureus. 2020 Nov 09;12(11):e11389. doi: 10.7759/cureus.11389.

Objective In this study, we aimed at comparing the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in healthcare workers (HCWs) in coronavirus disease 2019 (COVID-19) receiving and non-COVID-19 receiving hospitals in Peshawar, Pakistan. Methods This cross-sectional...

Cite
Noor M, Haq M, Ul Haq N, et al. Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?. Cureus. 2020;12(11):e11389doi: 10.7759/cureus.11389.
Noor, M., Haq, M., Ul Haq, N., Amin, S., Rahim, F., Bahadur, S., Ullah, R., Khan, M. A., Mahmood, A., & Gul, H. (2020). Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?. Cureus, 12(11), e11389. https://doi.org/10.7759/cureus.11389
Noor, Mohammad, et al. "Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?." Cureus vol. 12,11 (2020): e11389. doi: https://doi.org/10.7759/cureus.11389
Noor M, Haq M, Ul Haq N, Amin S, Rahim F, Bahadur S, Ullah R, Khan MA, Mahmood A, Gul H. Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?. Cureus. 2020 Nov 09;12(11):e11389. doi: 10.7759/cureus.11389. PMID: 33194502; PMCID: PMC7654561.
Copy Download .nbib Format: NLM
Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.

Neurology

Shelly S, Klein CJ, Dyck PJB, Paul P, Mauermann ML, Berini SE, Howe B, Fryer JP, Basal E, Bakri HM, Laughlin RS, McKeon A, Pittock SJ, Mills J, Dubey D.
PMID: 34635556
Neurology. 2021 Dec 14;97(24):e2392-e2403. doi: 10.1212/WNL.0000000000012932. Epub 2021 Oct 11.

BACKGROUND AND OBJECTIVE: Multiple studies highlighting the diagnostic utility of neurofascin-155 (NF155)-immunoglobulin G4 (IgG4) in chronic demyelinating inflammatory polyradiculoneuropathy (CIDP) have been published. However, few studies comprehensively address the long-term outcomes or clinical utility of NF155-immunoglobulin M (IgM) or...

Cite
Shelly S, Klein CJ, Dyck PJB, et al. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes. Neurology. 2021;97(24):e2392-e2403doi: 10.1212/WNL.0000000000012932.
Shelly, S., Klein, C. J., Dyck, P. J. B., Paul, P., Mauermann, M. L., Berini, S. E., Howe, B., Fryer, J. P., Basal, E., Bakri, H. M., Laughlin, R. S., McKeon, A., Pittock, S. J., Mills, J., & Dubey, D. (2021). Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes. Neurology, 97(24), e2392-e2403. https://doi.org/10.1212/WNL.0000000000012932
Shelly, Shahar, et al. "Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes." Neurology vol. 97,24 (2021): e2392-e2403. doi: https://doi.org/10.1212/WNL.0000000000012932
Shelly S, Klein CJ, Dyck PJB, Paul P, Mauermann ML, Berini SE, Howe B, Fryer JP, Basal E, Bakri HM, Laughlin RS, McKeon A, Pittock SJ, Mills J, Dubey D. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes. Neurology. 2021 Dec 14;97(24):e2392-e2403. doi: 10.1212/WNL.0000000000012932. Epub 2021 Oct 11. PMID: 34635556; PMCID: PMC8673722.
Copy Download .nbib Format: NLM
Surface Plasmon Resonance-Based Immunosensor for Igm Detection with Gold Nanoparticles.

Micromachines

Bereli N, Bakhshpour M, Topçu AA, Denizli A.
PMID: 34577735
Micromachines (Basel). 2021 Sep 10;12(9). doi: 10.3390/mi12091092.

In this work, a surface plasmon resonance (SPR) based immunosensor was prepared by the immobilization of the amine-functionalized gold nanoparticles (N-AuNPs) on the sensing surface to sense immunoglobulin M (IgM) antibodies in the aqueous solution and artificial plasma. The...

Cite
Bereli N, Bakhshpour M, Topçu AA, et al. Surface Plasmon Resonance-Based Immunosensor for Igm Detection with Gold Nanoparticles. Micromachines (Basel). 2021;12(9)doi: 10.3390/mi12091092.
Bereli, N., Bakhshpour, M., Topçu, A. A., & Denizli, A. (2021). Surface Plasmon Resonance-Based Immunosensor for Igm Detection with Gold Nanoparticles. Micromachines, 12(9), . https://doi.org/10.3390/mi12091092
Bereli, Nilay, et al. "Surface Plasmon Resonance-Based Immunosensor for Igm Detection with Gold Nanoparticles." Micromachines vol. 12,9 (2021). doi: https://doi.org/10.3390/mi12091092
Bereli N, Bakhshpour M, Topçu AA, Denizli A. Surface Plasmon Resonance-Based Immunosensor for Igm Detection with Gold Nanoparticles. Micromachines (Basel). 2021 Sep 10;12(9). doi: 10.3390/mi12091092. PMID: 34577735; PMCID: PMC8468630.
Copy Download .nbib Format: NLM
Maternal vs Fetal Origin of Placental Intervillous Thrombi.

American journal of clinical pathology

Sukhanova M, Mithal LB, Otero S, Azad HA, Miller ES, Jennings LJ, Shanes ED, Goldstein JA.
PMID: 34546332
Am J Clin Pathol. 2021 Sep 21; doi: 10.1093/ajcp/aqab139. Epub 2021 Sep 21.

OBJECTIVES: To determine maternal vs fetal origin for blood in placental intervillous thrombi (IVTs).METHODS: We used comparative analysis of microsatellites (short tandem repeats [STRs]), sex chromosome fluorescence in situ hybridization (FISH), and immunohistochemistry (IHC) for fetal (ɑ-fetoprotein [AFP]) and...

Cite
Sukhanova M, Mithal LB, Otero S, et al. Maternal vs Fetal Origin of Placental Intervillous Thrombi. Am J Clin Pathol. 2021;doi: 10.1093/ajcp/aqab139.
Sukhanova, M., Mithal, L. B., Otero, S., Azad, H. A., Miller, E. S., Jennings, L. J., Shanes, E. D., & Goldstein, J. A. (2021). Maternal vs Fetal Origin of Placental Intervillous Thrombi. American journal of clinical pathology, . https://doi.org/10.1093/ajcp/aqab139
Sukhanova, Madina, et al. "Maternal vs Fetal Origin of Placental Intervillous Thrombi." American journal of clinical pathology vol. (2021). doi: https://doi.org/10.1093/ajcp/aqab139
Sukhanova M, Mithal LB, Otero S, Azad HA, Miller ES, Jennings LJ, Shanes ED, Goldstein JA. Maternal vs Fetal Origin of Placental Intervillous Thrombi. Am J Clin Pathol. 2021 Sep 21; doi: 10.1093/ajcp/aqab139. Epub 2021 Sep 21. PMID: 34546332; PMCID: PMC8500002.
Copy Download .nbib Format: NLM
Natural Antibodies: Protecting Role of IgM in Glioblastoma and Brain Tumours.

Current pharmaceutical design

Semwal S, Boukherroub R, Savvides SN, Bouckaert J.
PMID: 34323181
Curr Pharm Des. 2021;27(45):4515-4529. doi: 10.2174/1381612827666210728103524.

BACKGROUND: Glioblastoma is a grade IV astrocytoma with an average survival span for patients of 18 months after initial diagnosis and no standard treatment protocol is available. Therefore, there is a need to search for novel approaches to target...

Cite
Semwal S, Boukherroub R, Savvides SN, et al. Natural Antibodies: Protecting Role of IgM in Glioblastoma and Brain Tumours. Curr Pharm Des. 2021;27(45):4515-4529doi: 10.2174/1381612827666210728103524.
Semwal, S., Boukherroub, R., Savvides, S. N., & Bouckaert, J. (2021). Natural Antibodies: Protecting Role of IgM in Glioblastoma and Brain Tumours. Current pharmaceutical design, 27(45), 4515-4529. https://doi.org/10.2174/1381612827666210728103524
Semwal, Shubham, et al. "Natural Antibodies: Protecting Role of IgM in Glioblastoma and Brain Tumours." Current pharmaceutical design vol. 27,45 (2021): 4515-4529. doi: https://doi.org/10.2174/1381612827666210728103524
Semwal S, Boukherroub R, Savvides SN, Bouckaert J. Natural Antibodies: Protecting Role of IgM in Glioblastoma and Brain Tumours. Curr Pharm Des. 2021;27(45):4515-4529. doi: 10.2174/1381612827666210728103524. PMID: 34323181.
Copy Download .nbib Format: NLM
Showing 577 to 582 of 582 entries